Literature DB >> 17186322

Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy.

Yutaka Takahashi1, Akira Ito, Iori Sumida, Takuyo Kozuka, Kotaro Gomi, Takayuki Nose, Teruo Ito, Takashi Yamashita.   

Abstract

PURPOSE: We investigated the difference between measured and manufacturer's nominal source strength in a large sample of a single model of (125)I seeds. Physical characteristics of single seed measurement by the well-type ionization chamber were also investigated to provide dosimetric data.
MATERIALS AND METHODS: A well-type ionization chamber with a single seed holder was used to measure source strength of all 1935 (125)I seeds implanted in the initial 28 patients in our hospital. Physical characteristics including linearity of readings for different integral time intervals, reproducibility, isotropy, and axial positional sensitivity were assessed. To calculate the source strength, the integral charge during 30 s was measured and converted to air kerma strength. The nominal activity stated by the manufacturer was compared with the measured value.
RESULTS: Linearity, reproducibility, and isotropy of the well-type ionization chamber were within 0.2%. Measured source strength was on average 2.1% (range -7.6% to +7.2%), lower than the nominal value. Standard deviation of all measured seeds was 2.0%. The maximum difference between the measured and the manufacturer's nominal source strength in each patient was -3.7%. The standard deviation averaged 1.6%.
CONCLUSION: The nominal source strength of the (125)I seeds agreed well with the measured value. Our study can be helpful as guidance for individual (125)I seed source strength measurement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186322     DOI: 10.1007/s11604-006-0088-0

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  6 in total

1.  Comparisons of a proposed five-seed assay method with the single-seed and batch assay methods for I-125 seeds in ultrasound-guided prostate implants.

Authors:  P C Lee; S J Starr; K Zuhlke; B J Moran
Journal:  Radiat Oncol Investig       Date:  1999

2.  Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

Authors:  Y Yu; L L Anderson; Z Li; D E Mellenberg; R Nath; M C Schell; F M Waterman; A Wu; J C Blasko
Journal:  Med Phys       Date:  1999-10       Impact factor: 4.071

3.  Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.

Authors:  Larry A DeWerd; M Saiful Huq; Indra J Das; Geoffrey S Ibbott; William F Hanson; Thomas W Slowey; Jeffrey F Williamson; Bert M Coursey
Journal:  Med Phys       Date:  2004-03       Impact factor: 4.071

4.  Quality assurance of I-125 seed permanent implant therapy using a self-color developing reflection-type dosimetry sheet film.

Authors:  Shunsuke Furutani; Hitoshi Ikushima; Kyosuke Ozaki; Masataka Oita; Motoharu Sasaki; Yoshihiro Takegawa; Hiromu Nishitani
Journal:  Radiat Med       Date:  2005-11

5.  Clinical implementation of AAPM Task Group 32 recommendations on brachytherapy source strength specification.

Authors:  J F Williamson; R Nath
Journal:  Med Phys       Date:  1991 May-Jun       Impact factor: 4.071

6.  Verification of manufacturer-supplied 125I and 103Pd air-kerma strengths.

Authors:  D E Mellenberg; R W Kline
Journal:  Med Phys       Date:  1995-09       Impact factor: 4.071

  6 in total
  5 in total

1.  Air kerma strength characterization of a GZP6 Cobalt-60 brachytherapy source.

Authors:  Mohammad Taghi Bahreyni Toossi; Mahdi Ghorbani; Ali Asghar Mowlavi; Mojtaba Taheri; Mohsen Layegh; Yasha Makhdoumi; Ali Soleimani Meigooni
Journal:  Rep Pract Oncol Radiother       Date:  2010-11-09

2.  Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan.

Authors:  Iori Sumida; Masahiko Koizumi; Yutaka Takahashi; Toshiyuki Ogata; Yuichi Akino; Fumiaki Isohashi; Koji Konishi; Yasuo Yoshioka; Takehiro Inoue
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

Review 3.  Current status and perspectives of brachytherapy for prostate cancer.

Authors:  Yasuo Yoshioka
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

4.  Novel Silicone-Coated 125I Seeds for the Treatment of Extrahepatic Cholangiocarcinoma.

Authors:  Lizhou Lin; Lili Guo; Weixing Zhang; Xiaobo Cai; Dafan Chen; Xinjian Wan
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

5.  Source strength assay of iodine-125 seeds sealed within sterile packaging.

Authors:  Yuki Otani; Takahiro Yamada; Shingo Kato; Naoto Shikama; Kazuto Funakoshi; Isao Kuroda; Hodaka Numasaki; Takayuki Nose; Takushi Dokiya; Masahiko Oguchi
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.